Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
We present use of a synthetic, injectable matrix-metalloproteinase (MMP)- responsive, bioactive hydrogel as an in situ forming scaffold to deliver thymosin β4 (Tβ4), a pro-angiogenic and pro-survival factor, along with vascular cells derived from human embryonic stem cells (hESC) in ischemic injuries to the heart in a rat model. The gel was found to substitute the degrading extracellular matrix in the infarcted myocardium of rats and to promote structural organization of native endothelial cells, while some of the delivered hESC-derived vascular cells formed de novo capillaries in the infarct zone. Magnetic resonance imaging (MRI) revealed that the microvascular grafts effectively preserved contractile performance 3 d and 6 wk after myocardial infarction, attenuated left ventricular dilation, and decreased infarct size as compared to infarcted rats treated with PBS injection as a control (3 d ejection fraction, + ~7%, P<0.001; 6 wk ejection faction, + ~12%, P<0.001). Elevation in vessel density was observed in response to treatment, which may be due in part to elevations in human (donor)-derived cytokines EGF, VEGF and HGF (1 d). Thus, a clinically relevant matrix for dual delivery of vascular cells and drugs may be useful in engineering sustained tissue preservation and potentially regenerating ischemic cardiac tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Self-citationIdentification of splenic reservoir monocytes and their deployment to inflammatory sites
Swirski, F. K., Nahrendorf, M., Etzrodt, M., Wildgruber, M., Cortez-Retamozo, V., Panizzi, P., Figueiredo, J.-L., Kohler, R. H., Chudnovskiy, A., Waterman, P., et al. (2009) · Science · doi:10.1126/science.1175202 · Cited by 2,221
Self-citationGnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., et al. (2005) · Nature Medicine · doi:10.1038/nm0405-367 · Cited by 1,677 · cited 1×
“Studies with bone marrow- or adipose tissue-derived stem cells and progenitor cells in animals and also in human clinical evaluation suggest that both neovascularization and paracrine effects play an important role in protecting native cardiomyocytes from death, enhancing the healing processes and preserving cardiac f…”
Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004) · Circulation Research · doi:10.1161/01.res.0000118601.37875.ac · Cited by 1,415
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389 · cited 1×
“The first hESC-based preclinical animal studies for repairing infarcted cardiac tissue used cardiomyocytes [6,7] or vascular cells [8,9].”
Repair of bone defects using synthetic mimetics of collagenous extracellular matrices
Lutolf, M. P., Weber, F. E., Schmoekel, H. G., Schense, J. C., Kohler, T., Müller, R., & Hubbell, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt818 · Cited by 850 · cited 4×
“We have demonstrated [19] that our synthetic hydrogel, mimicking key biochemical characteristics of collagen matrices [15], is able to retain the physically entrapped Tb4 over time, and to release it on-demand as MMP-2 and MMP-9 enzymes trigger gel degradation and release in vitro.”
InfluentialSelf-citation
Cited by
Zhang, K., Feng, Q., Fang, Z., Gu, L., & Bian, L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00071 · Cited by 394
Hydrogels for tissue engineering and regenerative medicine
Hunt, J. A., Chen, R., van Veen, T., & Bryan, N. (2014) · J. Mater. Chem. B · doi:10.1039/c4tb00775a · Cited by 377
Tallawi, M., Rosellini, E., Barbani, N., Cascone, M. G., Rai, R., Saint-Pierre, G., & Boccaccini, A. R. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.0254 · Cited by 366
Biomaterials for the Treatment of Myocardial Infarction
Rane, A. A., & Christman, K. L. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.001 · Cited by 226
Thymosin β 4 : a multi-functional regenerative peptide. Basic properties and clinical applications
Goldstein, A. L., Hannappel, E., Sosne, G., & Kleinman, H. K. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.634793 · Cited by 137
Metadata
- Authors
- Kraehenbuehl, T. P., Ferreira, L. S., Hayward, A. M., Nahrendorf, M., van der Vlies, A. J., Vasile, E., Weissleder, R., Langer, R., & Hubbell, J. A.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 32
- Issue
- 4
- Pages
- 1102-1109
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W1986549751
- Cited by
- 141
- References
- 6
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. https://app.cochat.ai/papers/10.1016/j.biomaterials.2010.10.005
- The paper
- Kraehenbuehl, T. P., Ferreira, L. S., Hayward, A. M., Nahrendorf, M., van der Vlies, A. J., Vasile, E., Weissleder, R., Langer, R., & Hubbell, J. A. (2011). Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials. https://doi.org/10.1016/j.biomaterials.2010.10.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.